These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23093903)

  • 21. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
    Sinsuebpol C; Chatchawalsaisin J; Kulvanich P
    Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hot-melt extrusion for enhanced delivery of drug particles.
    Miller DA; McConville JT; Yang W; Williams RO; McGinity JW
    J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of controlled-release cisplatin dry powders for inhalation against lung cancers.
    Levet V; Rosière R; Merlos R; Fusaro L; Berger G; Amighi K; Wauthoz N
    Int J Pharm; 2016 Dec; 515(1-2):209-220. PubMed ID: 27737810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and drying of miconazole and itraconazole nanosuspensions.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying.
    Leng D; Thanki K; Foged C; Yang M
    Pharm Res; 2018 Nov; 35(12):247. PubMed ID: 30386927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stability testing of meloxicam-containing microcomposites for inhalation].
    Pomázi A; Ambrus R; Szabóné Révész P
    Acta Pharm Hung; 2014; 84(2):55-62. PubMed ID: 25167700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
    Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
    J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
    Yang W; Tam J; Miller DA; Zhou J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2008 Sep; 361(1-2):177-88. PubMed ID: 18556158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model.
    McConville JT; Overhoff KA; Sinswat P; Vaughn JM; Frei BL; Burgess DS; Talbert RL; Peters JI; Johnston KP; Williams RO
    Pharm Res; 2006 May; 23(5):901-11. PubMed ID: 16715380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation.
    Moon C; Watts AB; Lu X; Su Y; Williams RO
    Mol Pharm; 2019 May; 16(5):1799-1812. PubMed ID: 30925839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of fast-dissolving low-density powders for improved lung deposition by spray drying of a nanosuspension.
    Šimková K; Joost B; Imanidis G
    Eur J Pharm Biopharm; 2020 Jan; 146():19-31. PubMed ID: 31734282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery.
    Hassanpour Aghdam M; Ghanbarzadeh S; Javadzadeh Y; Hamishehkar H
    Adv Pharm Bull; 2016 Mar; 6(1):57-64. PubMed ID: 27123418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
    Razavi Rohani SS; Abnous K; Tafaghodi M
    Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of PLGA-based itraconazole injectable nanospheres for sustained release.
    Bian X; Liang S; John J; Hsiao CH; Wei X; Liang D; Xie H
    Int J Nanomedicine; 2013; 8():4521-31. PubMed ID: 24311942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols.
    Muralidharan P; Mallory EK; Malapit M; Phan H; Ledford JG; Hayes D; Mansour HM
    RSC Adv; 2020 Nov; 10(68):41846-41856. PubMed ID: 33391731
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers.
    Acosta MF; Abrahamson MD; Encinas-Basurto D; Fineman JR; Black SM; Mansour HM
    AAPS J; 2020 Nov; 23(1):2. PubMed ID: 33200330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of fine solid-crystal suspension with enhanced solubility, stability, and aerosolization performance for dry powder inhalation.
    Lin L; Quan G; Peng T; Huang Z; Singh V; Lu M; Wu C
    Int J Pharm; 2017 Nov; 533(1):84-92. PubMed ID: 28903066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
    Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.